- Home
- CNNE vs AVIR Comparison
CNNE vs AVIR Comparison
Compare CNNE & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNNE | AVIR |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 497.5M | 450.9M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CNNE | AVIR |
|---|---|---|
| Price | $12.86 | $5.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $21.33 | $8.00 |
| AVG Volume (30 Days) | ★ 678.8K | 400.1K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | ★ 4.73% | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $499,700,000.00 | $351,367,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.37 | N/A |
| 52 Week Low | $10.46 | $2.46 |
| 52 Week High | $21.96 | $6.45 |
Technical Indicators
Market Signals| Indicator | CNNE | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 63.53 | 58.44 |
| Support Level | $11.54 | $3.28 |
| Resistance Level | $16.41 | $6.45 |
| Average True Range (ATR) | 0.46 | 0.25 |
| MACD | 0.24 | -0.02 |
| Stochastic Oscillator | 97.40 | 65.32 |
Price Performance
Historical ComparisonAbout CNNE Cannae Holdings Inc.
Cannae Holdings Inc is an investment holding company that acquires and actively manages equity interests in operating businesses across various industries. The Company focuses on long-term ownership and seeks to create value by supporting the growth and operations of its portfolio companies through management expertise and strategic oversight. The Company operates through four reportable segments: Restaurant Group, which includes the operations of O'Charleys and 99 Restaurants; Alight, which represents its ownership interest in a technology-enabled human capital and employee benefits solutions provider; Black Knight Football Club (BKFC), which holds interests in professional football clubs; and JANA, which represents its investment in an investment management firm.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.